  |
|
View Our Reports
Population Focus
The results below represent the entire WCHQ population (all providers, total population) for all WCHQ Ambulatory Care measures. Click the historical data links to see how the WCHQ population is improving over time.
| Chronic Care | ||
Diabetes: Blood Sugar (A1c) Testing  N=149,553  |  75.28%  21.37% |
|
Diabetes: Blood Sugar (A1c) Control N=149,553 |  60.50% 24.65% 11.50%  3.35% |
|
Diabetes: LDL Cholesterol Testing N=149,553 | 89.50% |
|
Diabetes: LDL Cholesterol Control N=149,553 | 59.80% 18.35% 11.22% 10.63% |
|
Diabetes: Kidney Function Monitored N=149,553 | 78.77% |
|
Diabetes: Blood Pressure Control N=149,553 | 51.10% |
|
Diabetes: All-or-None Process Measure (Optimal Testing) N=149,553 | 61.86% |
|
Diabetes: All-or-None Outcome Measure (Optimal Results) N=149,553 | 22.53% |
|
Uncomplicated Hypertension: Blood Pressure Control N=261,021 | 76.36% |
|
Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy N=61,773 | 91.39% |
|
Ischemic Vascular Disease: LDL Cholesterol Testing N=61,773 | 89.04% |
|
Ischemic Vascular Disease: LDL Cholesterol Control N=61,773 | 67.45% 13.08% 8.50% 10.97% |
|
Ischemic Vascular Disease: Blood Pressure Control N=61,773 | 81.70% |
|
Chronic Kidney Disease - CKD Care in Stages I, II and III: Annual eGFR N=25,078 | 97.65% |
|
Chronic Kidney Disease - CKD Care in Stages I, II and III: Blood Pressure Control N=25,078 | 52.59% |
|
Chronic Kidney Disease - CKD Care in Stages I, II and III: LDL Cholesterol Control N=25,078 | 57.23% 16.88% 10.00% 15.89% |
|
Chronic Kidney Disease - CKD Care in Stages I, II and III: LDL Cholesterol Testing N=25,078 | 84.28% |
|
Chronic Kidney Disease - CKD Care in Stages IV and V: Calcium Level N=2,493 | 91.17% |
|
Chronic Kidney Disease - CKD Care in Stages IV and V: eGFR (Estimated Glomerular Filtration Rate) test annually N=2,493 | 92.38% |
|
Chronic Kidney Disease - CKD Care in Stages IV and V: Hemoglobin test annually N=2,493 | 87.12% |
|
Chronic Kidney Disease - CKD Care in Stages IV and V: Intact Parathyroid Hormone (iPTH) N=2,493 | 64.05% |
|
Chronic Kidney Disease - CKD Care in Stages IV and V: Lipid Profile N=2,493 | 71.28% |
|
Chronic Kidney Disease - CKD Care in Stages IV and V: Most recent Blood pressure controlled to a level of less than 140/90 mm Hg N=2,493 | 70.02% |
|
Chronic Kidney Disease - CKD Care in Stages IV and V: Phosphorus Level N=2,493 | 69.23% |
|
| Preventive Care | ||
Breast Cancer Screening N=398,797 | 77.55% |
|
Cervical Cancer Screening N=667,512 | 79.40% |
|
Colorectal Cancer Screening N=776,210 | 74.38% |
|
Screening for Osteoporosis N=212,785 | 79.82% |
|
Chronic Kidney Disease: Screening N=432,901 | 87.93% |
|
Adults with Pneumococcal Vaccinations N=433,767 | 82.02% |
|
Adult Screening for Tobacco Use N=1,399,603 | 98.00% |
|
Tobacco User Receiving Tobacco Cessation Advice N=235,351 | 71.48% |
|
